NCT06951230

Brief Summary

The aim of the study is to compare the effectiveness and safety of scalp block versus intravenous fentanyl in pain control intraoperatively in craniotomy patients. Most of the previous studies compared the effect of scalp block versus fentanyl or opioids in postoperative pain

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for phase_1 postoperative-pain

Timeline
Completed

Started Feb 2024

Shorter than P25 for phase_1 postoperative-pain

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2024

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2024

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2024

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

April 4, 2025

Completed
26 days until next milestone

First Posted

Study publicly available on registry

April 30, 2025

Completed
Last Updated

April 30, 2025

Status Verified

February 1, 2025

Enrollment Period

6 months

First QC Date

April 4, 2025

Last Update Submit

April 26, 2025

Conditions

Keywords

scalp blockpaincraniotomyPain control

Outcome Measures

Primary Outcomes (1)

  • intra-operative hemodynamic stability

    Recording the mean arterial blood pressure and heart rate readings will be obtained before induction , on skin pinning, on skin incision , 1 hour post induction, after 2hours and every hour hour till the end of the surgery

    intra-operatively

Secondary Outcomes (1)

  • fentanyl consumption

    intra-operatively

Other Outcomes (1)

  • post-operative pain

    1 hour post-operatively

Study Arms (2)

fentanyl group

ACTIVE COMPARATOR

patients will receive general anesthesia followed by intravenous fentanyl (1ug/kg/hr)

Drug: Fentanyl injection

scalp block group

ACTIVE COMPARATOR

patients will receive general anesthesia followed by the scalp block.

Drug: Fentanyl injectionProcedure: scalp block

Interventions

Fentanyl 1mcg/kg will be given before skin incision and Mayfield placement and followed up by fentanyl 1mcg/kg/hr, along the operation.

fentanyl groupscalp block group
scalp blockPROCEDURE

The scalp block procedure is performed with the patient in the supine position, utilizing surface landmarks for guidance. The local anesthetic is injected into the nerves after careful aspiration and under strict aseptic technique. The nerves that are typically injected include the supraorbital, supratrochlear, zygomaticotemporal, auriculotemporal, as well as the lesser and greater occipital nerves, with or without the inclusion of the third occipital nerve. The volume of 0.5% bupivacaine injected should not exceed 2 ml at each site.

scalp block group

Eligibility Criteria

Age20 Years - 60 Years
Sexall(Gender-based eligibility)
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Age between 20 and 60
  • Physical status: ASA I and II
  • Elective operation, under general anaesthesia,

You may not qualify if:

  • ASA above ll
  • Patients with known uncontrolled comorbidities such as hypertension or Diabetes Mellites
  • Coagulopathy, use of anti-coagulant or anti-platelet therapy.
  • Known allergies to drugs used (Bupivacaine)
  • Infection at the site of injection
  • History of cranial nerve affection
  • Emergency craniotomy.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ain Shams University

Cairo, Cairo Governorate, 11111, Egypt

Location

MeSH Terms

Conditions

Pain, PostoperativePainAgnosia

Interventions

Fentanyl

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsNeurologic ManifestationsSigns and SymptomsPerceptual DisordersNeurobehavioral ManifestationsNervous System Diseases

Intervention Hierarchy (Ancestors)

PiperidinesHeterocyclic Compounds, 1-RingHeterocyclic Compounds

Study Officials

  • Hegazy

    Ain Shams University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 1
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, CARE PROVIDER
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 4, 2025

First Posted

April 30, 2025

Study Start

February 1, 2024

Primary Completion

August 1, 2024

Study Completion

September 1, 2024

Last Updated

April 30, 2025

Record last verified: 2025-02

Data Sharing

IPD Sharing
Will share

All dana will be shared once study is completed

Shared Documents
STUDY PROTOCOL, SAP, ICF
Time Frame
before 6/2025
Access Criteria
free

Locations